OVID - Ovid Therapeutics Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 590.93M
Enterprise Value 334.77M
Trailing P/E N/A
Forward P/E 1-1.12
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)N/A
Price/Book (mrq)1.59
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6-0.66

Trading Information

Stock Price History

Beta (3Y Monthly) 2.24
52-Week Change 3-77.26%
S&P500 52-Week Change 36.90%
52 Week High 311.0200
52 Week Low 31.5300
50-Day Moving Average 32.0354
200-Day Moving Average 32.1795

Share Statistics

Avg Vol (3 month) 3616.48k
Avg Vol (10 day) 3277.6k
Shares Outstanding 524.63M
Float 15.55M
% Held by Insiders 141.41%
% Held by Institutions 125.99%
Shares Short (Jun 28, 2019) 4953.61k
Short Ratio (Jun 28, 2019) 44.08
Short % of Float (Jun 28, 2019) 44.11%
Short % of Shares Outstanding (Jun 28, 2019) 42.46%
Shares Short (prior month May 31, 2019) 4939.97k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Mar 31, 2019


Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-45.64%
Return on Equity (ttm)-81.33%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -52.86M
Net Income Avi to Common (ttm)-52.6M
Diluted EPS (ttm)-2.0180
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)59.64M
Total Cash Per Share (mrq)1.54
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)7.78
Book Value Per Share (mrq)1.48

Cash Flow Statement

Operating Cash Flow (ttm)-45.5M
Levered Free Cash Flow (ttm)-26.52M